TheraCyte, Inc. manufactures cell encapsulation systems that enable the development of cell-based therapeutic products for treating chronic and recurrent diseases including diabetes, infection control, protein deficiencies and immunological disorders.
TheraCyte, Inc.’s mission is to enable the development of therapeutic cell implants for the treatment of human diseases. The company carries out its mission by implementing a partnering strategy with major pharmaceutical and biotechnology companies.
TheraCyte, Inc. was founded in 1999 as a spin-out from Baxter Healthcare Corporation. The company is based on a proprietary medical device technology developed by Baxter scientists to deliver cell and gene therapies.
This effort resulted in a number of innovations in the design, construction and use of certain biocompatible materials, and is protected by 20 U.S. patents as well as numerous associated … (use website info for the rest of the page.)